MUSTANG BIO, INC. Cash and Cash Equivalents, Period Increase (Decrease)
MUSTANG BIO, INC. (MBIO) reported Cash and Cash Equivalents, Period Increase (Decrease) of $5.71 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2017-11-14
- MUSTANG BIO, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was -$20.58M, a 285.11% decline year-over-year.
- MUSTANG BIO, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2016-09-30 was $11.12M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month |
|---|---|---|---|
| 2017-09-30 | -$20.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $5.71M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $26.29M 10-Q · filed 2017-08-14 | ||
| 2016-09-30 | $11.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $11.12M 10-Q · filed 2017-11-14 | |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |